How the semaglutide injection mechanism of action reduces appetite

What is GLP-1, and why does the injection replicate it?

GLP-1 stands for glucagon-like peptide-1. Your intestinal cells release it within minutes of eating, and it does several things at once: it tells the pancreas to release insulin, it signals the brain to stop eating, and it slows the passage of food from the stomach into the small intestine. The trouble is, natural GLP-1 breaks down in the blood within two to three minutes. It barely has time to act before your body clears it.

Semaglutide is a synthetic version of that hormone, chemically modified so it binds to albumin (a protein in the blood) which shields it from rapid breakdown. The result is a molecule with a half-life of around seven days, long enough to sustain the hormone's effects across a full week on a single dose. That week-long presence is the engineering behind the once-weekly injection schedule used for semaglutide weight-loss injections.

Because semaglutide activates the GLP-1 receptor rather than creating a new pathway, the body recognises its effects as familiar. The NHS describes semaglutide as working by mimicking a hormone that controls blood sugar and appetite, a straightforward summary of a mechanism that is, at the molecular level, surprisingly elegant. You can read the NHS patient overview at nhs.uk/medicines/semaglutide.

What does the GLP-1 receptor actually do when semaglutide binds it?

The GLP-1 receptor sits in several places at once, and each location contributes a different part of the appetite-suppressing effect.

In the pancreas, receptor activation prompts insulin release in response to blood glucose, useful for blood-sugar regulation, and part of why semaglutide is also used in type 2 diabetes management under different brand names. For weight management, the effects elsewhere matter more.

In the stomach, receptor activation delays gastric emptying. Food moves more slowly from your stomach into the small intestine. Practically, that means the physical sensation of fullness arrives faster and lingers longer, you reach the end of a smaller meal still satisfied. Many people on semaglutide injections describe this as the most noticeable early change: portion sizes that felt modest a few weeks ago become genuinely enough.

In the hypothalamus and brainstem (areas that regulate hunger, satiety, and food reward) GLP-1 receptor activation reduces the appetite signals that normally push you to seek food. Research suggests it also blunts the dopamine-driven reward response to highly palatable foods, which may explain why cravings for specific foods often ease. This brain-level effect is distinct from willpower; it is a direct pharmacological signal, which is why clinicians describe weight as a biology problem, not a motivation one.

The combined effect of slower digestion, earlier satiety, and reduced cravings is what drives the weight-loss results seen in the STEP 1 trial, published in the New England Journal of Medicine, where adults on 2.4mg semaglutide lost around 15% of their body weight on average over 68 weeks.

How does this differ from what tirzepatide does?

Semaglutide targets one receptor: GLP-1. Tirzepatide, the active ingredient in Mounjaro, adds a second: GIP. GIP (glucose-dependent insulinotropic polypeptide) is another gut hormone involved in energy storage and fat metabolism. Activating both pathways together appears to produce greater average weight loss in head-to-head trials, the SURMOUNT-5 study found tirzepatide outperformed semaglutide 2.4mg on mean weight reduction over 72 weeks.

That does not make semaglutide the lesser option for every person. Tolerability, medical history, existing conditions, and how your body responds all shape which medicine a prescriber considers appropriate. For people who prefer to avoid injections entirely, Wegovy is now also available as a once-daily tablet; our page on semaglutide without an injection covers how that works. The prescriber's job is to weigh those factors, not to rank medicines in the abstract.

If you are curious about what the cost of semaglutide treatment looks like in practice, that page sets out what a private prescription includes and what to look for when comparing providers.

What does the mechanism mean for side effects and practical timing?

Because semaglutide slows gastric emptying, the most common early side effects are gastrointestinal: nausea, loose stools, constipation, or some combination, particularly after starting or after a dose increase. These are a direct consequence of the mechanism, the stomach is adjusting to a slower rhythm. Most people find they settle within days to a couple of weeks as the body acclimatises.

The once-weekly schedule means there is some flexibility in which day you inject, provided you keep roughly seven days between doses. A question our prescribers hear regularly is whether it matters if the usual day shifts, say, around a bank holiday or a dose that arrives just after payday. Staying within the seven-day window is what counts; your prescriber or the Patient Information Leaflet will confirm the specifics for your situation.

Proper storage matters because the mechanism depends on the molecule staying intact. Semaglutide pens need refrigeration until first use. Our guide to storing semaglutide injections covers the fridge-to-room-temperature window in full, because handling affects efficacy. Similarly, injection technique (using a clean site, rotating locations, and swabbing beforehand) supports consistent absorption. Alcohol swabs are a straightforward addition to your routine if you do not already use them.

If you experience severe, persistent stomach pain that radiates to your back, seek urgent medical attention. This may be a sign of pancreatitis, which the MHRA flagged in a Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. Any side effects you suspect are linked to your treatment can be reported through the MHRA Yellow Card scheme.

Understanding the mechanism is a useful starting point, but whether semaglutide is the right choice involves a full clinical picture. If you'd like a prescriber to review your situation, you can start your free consultation and receive a same-day clinical review by a GPhC-registered prescriber.